11-13 November 2025
Congress Center Basel -
Basel, Switzerland
Connect with Leaders in Oligonucleotide & Peptide Therapeutics
This is where the future comes to life, and these top companies are leading the way with cutting-edge technology, groundbreaking ideas, and bold visions. Whether you’re looking for fresh inspiration, potential partnerships, or the latest advancements, this list is your connection to the industry’s top innovators.
Visit their booths, explore their tech, and book meetings to connect with the leaders shaping what’s next.
Find where our sponsors are located on the show floor!
With more than 27 years of experience in the nucleic acid industry, Hongene is a specialist CDMO and raw materials supplier, committed to providing high-quality and high-value products and services with best-in-class lead times. Our world-leading manufacturing capacity of phosphoramidites is 58 tons and 54,000 liters for NTP per year, sufficient to support customers from small-scale to commercial production.
-
Tuesday, 11 November 2025 12:15 - 12:45 CET (Central European Time, GMT+01:00)
Luncheon Spotlight Presentation 2
Chemoenzymatic Ligation: Advancing Next-Generation Manufacturing Technologies for siRNA and sgRNA
This talk will explore the application of chemoenzymatic ligation for the manufacturing of high-purity siRNA and sgRNA, enabling scalable and sustainable drug production. Case studies will highlight process design, strategies for purity and impurity control, and recent advancements achieved with our engineered thermostable ligase. Emphasis will be placed on the technology’s potential to address current limitations in traditional synthesis methods, supporting the anticipated growth in demand for high-quality siRNA and gene-editing drugs over the next decade.
Speaker:
David Butler, PhD
Chief Technology Officer at Hongene Biotech Corporation
Built on the legacy of accelerating innovation and backed by a vast experience in drug discovery, development and manufacturing our mission is to relentlessly work for the success of our clients and to build long-term relationships through a holistic approach to accelerate the journey of a molecule from the laboratory to market.
-
Wednesday, 12 November 2025 at 12:50 - 1:00 CET
TIDES Talks in Poster and Exhibit Hall
Modern Methodologies for the Design, Synthesis, Characterization, and Scale-Up of Novel Peptides
Peptide therapeutics in pharmaceutical landscape is evolving rapidly. It is driven by advancements in synthesis technologies, analytical characterization, and scalable manufacturing processes. This presentation will explore innovative strategies to improve process efficiencies and overcome challenges in peptide manufacturing, including solid-phase synthesis, liquid-phase synthesis, purification, and isolation. Integrating analytical techniques for in-process monitoring and quality control ensures product consistency and regulatory compliance.
Case studies highlighting successful manufacturing scale-up, process optimization, and novel technologies in peptide CMC (Chemistry, Manufacturing, and Controls) will be discussed to provide a comprehensive overview of best practices to accelerate therapeutic development of peptides from lab to market.
Speaker:
Balakumaran Kesavan, PhD
Group Leader – Analytical R&D, Small Molecules and Peptides CDMO at Aurigene Pharmaceutical Services
Connect with Industry Leaders
With more than 27 years of experience in the nucleic acid industry, Hongene is a specialist CDMO and raw materials supplier, committed to providing high-quality and high-value products and services with best-in-class lead times. Our world-leading manufacturing capacity of phosphoramidites is 58 tons and 54,000 liters for NTP per year, sufficient to support customers from small-scale to commercial production.
Built on the legacy of accelerating innovation and backed by a vast experience in drug discovery, development and manufacturing our mission is to relentlessly work for the success of our clients and to build long-term relationships through a holistic approach to accelerate the journey of a molecule from the laboratory to market.
Featured Insights
















